( 概要 ) 日本国内で治験を実施するためのオペレーションチームリーダーとして,国内外のステークホルダーとの協議•交渉など,エキスパートとしてのコミュニケーションを通じ,品質を確保した臨床試験を計画通りに遂行する。 ( 具体的な業務例 ) •試験実施施設の選定戦略,症例組み入れプラン•戦略の作成及び実行 •試験遂行のための現場の責任者としてモニターへの指示及びモニターへの助言 •試験全体の進捗および GCP , SOP に沿った臨床試験の実施と品質の確保 •国際共同試験の場合,海外担当者からの指示の正確な把握及び協議を含めた円滑なコミュニケーション •試験における Risk & Issue Management •治験契約締結交渉,データ固定, GCP • SOP に基づくモニタリングに対するモニターへのフォロー •チームビルディング,ステークホルダーマネジメントによるチーム作り •社内の改善活動 / Task force team への参加 •試験全体の予算の管理 Position Summary: The
Description Key responsibilities 1. Directly manage a medium sized team responsible for effective execution of Dr. Ci:Labo programs in alignment with category strategies driven efficiently through the most efficient technologies using aligned work processes. 2. Stakeholder
Description Who We Are : At Kenvue, we realize the extraordinary power of everyday care. Built on over a century of heritage and rooted in science, were the house of iconic brands - including Aveeno®, BAND-AID®
Description (Position Summary) Play an important role as a core team member via individually supporting project of marketing planning via 1) efficient media planning, 2) effectiveness of message deliver and 3) always on optimization for further
Johnson & Johnson Innovation, a part of Johnson & Johnsons Family of Companies, is currently recruiting for a Senior Manager / Associate Director, Early Innovation Partnering to be based in Tokyo, Japan. Johnson & Johnson (J&J) is
•Position Purpose •Develop and deliver strategies to give our company customer facing teams a competitive edge with personalized engagement as well as data-driven insights using advanced commercial processes, systems and tools •Key Responsibility Areas •Establish the
SUMMARY Responsible and accountable for Medical Affairs strategy of Urological cancer products C ollaborates with internal and external stakeholders including key opinion leaders to develop and implement the overall M edical Affairs strategy for product lifecycle
Responsibilities: • Manage the implementation of automation technologies to streamline creating and updating mandatory materials. • Drive comprehensive assessments of available automation technologies tailored to pharmaceutical documentation. • Prioritize vendors with experience in similar automation projects
